Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to evaluate the efficacy of topical products in providing protection against the visible light and ultraviolet A1 (UVA1) part of sunlight. Ultraviolet radiation and visible light are both components of sunlight that reach the earth. It is important to test these topical products against visible light and UVA1 because our current sunscreens may not protect against these very well.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04181476
Study type Interventional
Source Henry Ford Health System
Contact
Status Active, not recruiting
Phase Phase 2
Start date November 5, 2019
Completion date June 2022

See also
  Status Clinical Trial Phase
Completed NCT05300542 - Efficacy Study of a Novel Skin Health Product to Reduce an UVB Induced Erythema N/A
Completed NCT05865431 - Singlet Oxygen Quantification After Skin Exposure to Ultraviolet A (UVA) Light N/A
Completed NCT05926791 - Photoprotective Effects of a SPF50+ Sunscreen on Skin Genotoxicity Induced by Repeated Chronic Outdoor Sun Exposure
Completed NCT05398237 - An Assessment of TLR4 and TOPK/PRPK Signaling in Sun Damaged Human Skin Acutely Exposed to Solar Simulated Light N/A
Completed NCT05162300 - Same-Day Combination of VI Peel and Botox for Correction of Sun Damage, Fine Lines and Wrinkles Phase 4
Completed NCT03110159 - DUSA: Cyclic PDT for the Prevention of AK & NMSC in Solid Organ Transplant Recipients Phase 1/Phase 2
Completed NCT03006185 - Laser and Microdermabrasion Before Photodynamic Therapy for Actinic Keratoses in Field-cancerized Skin Phase 2
Enrolling by invitation NCT03007589 - Natural Sunlight Protection and Simulated Sunlight Protection Offered by Sunscreens and Fabrics N/A